A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast Cancer
Clinical trial NCT02120417 · TERMINATED
Trial details
- NCT number
- NCT02120417
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2016-02-01
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.